tiprankstipranks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market
VRCA
Verrica Pharmaceuticals
RESEARCH TOOLSreports

Verrica Pharmaceuticals (VRCA) Stock News & Sentiment

Compare
484 Followers
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
Premium
Ratings
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
19d ago
VRCA
Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet
21d ago
VRCA
YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint
Premium
Company Announcements
YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint
2M ago
VEEV
VRCA
Verrica Pharmaceuticals Adds Caligan Partner to Board
Premium
Company Announcements
Verrica Pharmaceuticals Adds Caligan Partner to Board
3M ago
8K
VRCA
Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns
Premium
Ratings
Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns
4M ago
VRCA
Verrica Pharmaceuticals Secures $50M Financing Deal
Premium
Company Announcements
Verrica Pharmaceuticals Secures $50M Financing Deal
4M ago
8K
VRCA
Verrica Pharmaceuticals Reports Strong Growth Amid Challenges
Premium
Company Announcements
Verrica Pharmaceuticals Reports Strong Growth Amid Challenges
4M ago
VRCA
More VRCA News >

VRCA News on the Web

Verrica Pharmaceuticals Faces Director Oversight Probe: What Investors Should Know After Rosen Law Firm Announcement
Market Chameleon
Neutral
Verrica Pharma Q4 And FY25 Revenue Improves; Plans Second Phase 3 Program For VP-102 In Mid 2026
rttnews
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)
TipRanks News
Neutral
Verrica Pharmaceuticals Inc (VRCA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...
GuruFocus News
Bullish
Q4 2025 Verrica Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News
Neutral
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
TipRanks News
Bullish
Verrica Pharmaceuticals reports Q4 adjusted EPS (51c), consensus (79c)
TipRanks News
Bullish
Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRCA’s Media Buzz Sentiment?
Currently, no data Available
What is VRCA’s weekly average amount of articles?
Currently, no data Available
What is VRCA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
PYXSPyxis Oncology
WXIBFWuxi Biologics (Cayman)
KODKodiak Sciences
SHTDYSinopharm Group Co
GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
Showing the stocks with the most bullish news sentiment over the past week